News

From Diagnosis To Cure: Is AI The Key To Eradicating Cancer?
Although still in its infancy, this technology has already shown remarkable effectiveness in detecting and treating cancer, ...
Health Affairs1d
Podcast: FDA Vague Efforts to Scale Generative AI Internally By End of June
Health Affairs' Jeff Byers welcomes Senior Editor Michael Gerber back to the program to discuss the Food and Drug ...
BioSpace13d
FDA, NIH Accelerate Shift Away From Animal Research as Experts Warn of Limitations
The FDA and NIH recently announced plans to phase out animal testing requirements for some therapies. While organoid and AI ...
AI In Healthcare Market Revenue worth $187.7 Billion by 2030 - Exclusive Study by The Research Insights
The global AI In Healthcare Market size is projected to be valued at USD 26.6 Billion in 2024 and reach USD 187.7 billion by ...
Business Wire11d
Tempus Announces a Collaboration with Verastem to Develop CDx for First-Ever FDA-Approved KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer Combination Treatment
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance ... basis of the recent U.S. Food and Drug Administration’s (FDA) accelerated ...